Chronic treatment with neuroleptics alters neutral endopeptidase 24.11 activity in rat brain regions

Christopher S. Konkoy, Mary G. Oakes, Thomas P Davis

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Chronic administration of neuroleptics has been shown to affect the endogenous levels, mRNA, posttranslational processing, and metabolism of neuropeptides in specific regions of rat brain. Neutral endopeptidase 24.11 (NEP) is known to metabolize a variety of neuropeptide substrates, including the enkephalins and neurotensin, thus modifying or terminating the bioactivity of such peptides. In the present study, chronic treatment with haloperidol (1 mg/kg/day, 12 days) increased NEP activity in nucleus accumbens, and chronic treatment with chlorpromazine (4 mg/kg/day, 12 days) increased NEP activity in caudate putamen. Higher dosages with either compound did not significantly alter NEP activity, and none of the treatments altered NEP activity in the hypothalamus. Chronic treatment with apomorphine (5 mg/kg/day, 12 days) decreased NEP activity in both nucleus accumbens and caudate putamen. These data suggest that chronic treatment with neuroleptic drugs may lead to regionally specific alterations in the metabolism of neuropeptides.

Original languageEnglish (US)
Pages (from-to)1017-1020
Number of pages4
JournalPeptides
Volume14
Issue number5
DOIs
StatePublished - 1993

Fingerprint

Neprilysin
Antipsychotic Agents
Rats
Brain
Neuropeptides
Putamen
Nucleus Accumbens
Metabolism
Neurotensin
Apomorphine
Enkephalins
Chlorpromazine
Haloperidol
Bioactivity
Hypothalamus
Messenger RNA
Peptides
Substrates
Processing

Keywords

  • Antipsychotics
  • Chlorpromazine
  • Dopamine
  • Haloperidol
  • Neuroleptics
  • Neutral endopeptidase (EC 3.4.24.11)
  • Peptidases

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology
  • Physiology
  • Cellular and Molecular Neuroscience

Cite this

Chronic treatment with neuroleptics alters neutral endopeptidase 24.11 activity in rat brain regions. / Konkoy, Christopher S.; Oakes, Mary G.; Davis, Thomas P.

In: Peptides, Vol. 14, No. 5, 1993, p. 1017-1020.

Research output: Contribution to journalArticle

Konkoy, Christopher S. ; Oakes, Mary G. ; Davis, Thomas P. / Chronic treatment with neuroleptics alters neutral endopeptidase 24.11 activity in rat brain regions. In: Peptides. 1993 ; Vol. 14, No. 5. pp. 1017-1020.
@article{5c925c0cc61e4254abdf5710ca2a69a4,
title = "Chronic treatment with neuroleptics alters neutral endopeptidase 24.11 activity in rat brain regions",
abstract = "Chronic administration of neuroleptics has been shown to affect the endogenous levels, mRNA, posttranslational processing, and metabolism of neuropeptides in specific regions of rat brain. Neutral endopeptidase 24.11 (NEP) is known to metabolize a variety of neuropeptide substrates, including the enkephalins and neurotensin, thus modifying or terminating the bioactivity of such peptides. In the present study, chronic treatment with haloperidol (1 mg/kg/day, 12 days) increased NEP activity in nucleus accumbens, and chronic treatment with chlorpromazine (4 mg/kg/day, 12 days) increased NEP activity in caudate putamen. Higher dosages with either compound did not significantly alter NEP activity, and none of the treatments altered NEP activity in the hypothalamus. Chronic treatment with apomorphine (5 mg/kg/day, 12 days) decreased NEP activity in both nucleus accumbens and caudate putamen. These data suggest that chronic treatment with neuroleptic drugs may lead to regionally specific alterations in the metabolism of neuropeptides.",
keywords = "Antipsychotics, Chlorpromazine, Dopamine, Haloperidol, Neuroleptics, Neutral endopeptidase (EC 3.4.24.11), Peptidases",
author = "Konkoy, {Christopher S.} and Oakes, {Mary G.} and Davis, {Thomas P}",
year = "1993",
doi = "10.1016/0196-9781(93)90080-Z",
language = "English (US)",
volume = "14",
pages = "1017--1020",
journal = "Peptides",
issn = "0196-9781",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Chronic treatment with neuroleptics alters neutral endopeptidase 24.11 activity in rat brain regions

AU - Konkoy, Christopher S.

AU - Oakes, Mary G.

AU - Davis, Thomas P

PY - 1993

Y1 - 1993

N2 - Chronic administration of neuroleptics has been shown to affect the endogenous levels, mRNA, posttranslational processing, and metabolism of neuropeptides in specific regions of rat brain. Neutral endopeptidase 24.11 (NEP) is known to metabolize a variety of neuropeptide substrates, including the enkephalins and neurotensin, thus modifying or terminating the bioactivity of such peptides. In the present study, chronic treatment with haloperidol (1 mg/kg/day, 12 days) increased NEP activity in nucleus accumbens, and chronic treatment with chlorpromazine (4 mg/kg/day, 12 days) increased NEP activity in caudate putamen. Higher dosages with either compound did not significantly alter NEP activity, and none of the treatments altered NEP activity in the hypothalamus. Chronic treatment with apomorphine (5 mg/kg/day, 12 days) decreased NEP activity in both nucleus accumbens and caudate putamen. These data suggest that chronic treatment with neuroleptic drugs may lead to regionally specific alterations in the metabolism of neuropeptides.

AB - Chronic administration of neuroleptics has been shown to affect the endogenous levels, mRNA, posttranslational processing, and metabolism of neuropeptides in specific regions of rat brain. Neutral endopeptidase 24.11 (NEP) is known to metabolize a variety of neuropeptide substrates, including the enkephalins and neurotensin, thus modifying or terminating the bioactivity of such peptides. In the present study, chronic treatment with haloperidol (1 mg/kg/day, 12 days) increased NEP activity in nucleus accumbens, and chronic treatment with chlorpromazine (4 mg/kg/day, 12 days) increased NEP activity in caudate putamen. Higher dosages with either compound did not significantly alter NEP activity, and none of the treatments altered NEP activity in the hypothalamus. Chronic treatment with apomorphine (5 mg/kg/day, 12 days) decreased NEP activity in both nucleus accumbens and caudate putamen. These data suggest that chronic treatment with neuroleptic drugs may lead to regionally specific alterations in the metabolism of neuropeptides.

KW - Antipsychotics

KW - Chlorpromazine

KW - Dopamine

KW - Haloperidol

KW - Neuroleptics

KW - Neutral endopeptidase (EC 3.4.24.11)

KW - Peptidases

UR - http://www.scopus.com/inward/record.url?scp=0027486204&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027486204&partnerID=8YFLogxK

U2 - 10.1016/0196-9781(93)90080-Z

DO - 10.1016/0196-9781(93)90080-Z

M3 - Article

C2 - 7904340

AN - SCOPUS:0027486204

VL - 14

SP - 1017

EP - 1020

JO - Peptides

JF - Peptides

SN - 0196-9781

IS - 5

ER -